Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Verbascoside attenuates angiotensin-induced hypertension by inhibiting endoplasmic reticulum stress via the
Kai Liu1,2, Fansen Meng1,2, Xiaojian Zhao1,2
1Department of Hypertension, Henan Provincial People's Hospital, Zhengzhou City, Henan Province, China.
Background:
Verbascoside (VB) inhibits endoplasmic reticulum stress (ERS), but its therapeutic potential in hypertension (HTN) is unclear.
Aim:
To investigate whether VB inhibits ERS by modulating the Nur77/GFPT2/CHOP axis, thereby ameliorating angiotensin II (Ang II)-induced HTN.
Methods:
The cell biological behaviour of HUVECs was determined by CCK-8, LDH kit, scratch assay, and adhesion assay. Oxidative stress factor levels were detected by flow cytometry and kits. The levels of ERS and the Nur77/GFPT2/CHOP pathway-related proteins were examined through Western blot.
Results:
VB increased the viability of Ang II-treated HUVECs, inhibited LDH release, and reduced cell migration and adhesion. VB also reduced ERS marker protein levels, while inhibiting oxidative stress and modulating the Nur77/GFPT2/CHOP pathway. VB lowered blood pressure and increased elastic fibre deposition in HTN mice, and Nur77 agonists enhanced the protective impact of VB.
Conclusion:
VB hindered Ang II-induced endothelial dysfunction and ERS through modulating the Nur77/GFPT2/CHOP pathway.
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of β1 Blockers
Hormonal Regulation

